BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16132350)

  • 1. Tissue distribution of indinavir administered as solid lipid nanocapsule formulation in mdr1a (+/+) and mdr1a (-/-) CF-1 mice.
    Pereira de Oliveira M; Garcion E; Venisse N; Benoit JP; Couet W; Olivier JC
    Pharm Res; 2005 Nov; 22(11):1898-1905. PubMed ID: 16132350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation.
    Megard I; Garrigues A; Orlowski S; Jorajuria S; Clayette P; Ezan E; Mabondzo A
    Brain Res; 2002 Feb; 927(2):153-67. PubMed ID: 11821009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.
    Shen J; Carcaboso AM; Hubbard KE; Tagen M; Wynn HG; Panetta JC; Waters CM; Elmeliegy MA; Stewart CF
    Cancer Res; 2009 Jul; 69(14):5885-92. PubMed ID: 19567673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine antinociception is enhanced in mdr1a gene-deficient mice.
    Zong J; Pollack GM
    Pharm Res; 2000 Jun; 17(6):749-53. PubMed ID: 10955852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
    de Vries NA; Zhao J; Kroon E; Buckle T; Beijnen JH; van Tellingen O
    Clin Cancer Res; 2007 Nov; 13(21):6440-9. PubMed ID: 17975156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.
    Dagenais C; Zong J; Ducharme J; Pollack GM
    Pharm Res; 2001 Jul; 18(7):957-63. PubMed ID: 11496955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
    Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
    J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice.
    Zhou L; Schmidt K; Nelson FR; Zelesky V; Troutman MD; Feng B
    Drug Metab Dispos; 2009 May; 37(5):946-55. PubMed ID: 19225039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of P-glycoprotein on the brain penetration and brain pharmacodynamic activity of the MEK inhibitor cobimetinib.
    Choo EF; Ly J; Chan J; Shahidi-Latham SK; Messick K; Plise E; Quiason CM; Yang L
    Mol Pharm; 2014 Nov; 11(11):4199-207. PubMed ID: 25243894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results.
    Yamazaki M; Neway WE; Ohe T; Chen I; Rowe JF; Hochman JH; Chiba M; Lin JH
    J Pharmacol Exp Ther; 2001 Mar; 296(3):723-35. PubMed ID: 11181899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice.
    Leusch A; Volz A; Müller G; Wagner A; Sauer A; Greischel A; Roth W
    Eur J Pharm Sci; 2002 Aug; 16(3):119-28. PubMed ID: 12128165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice.
    Kawahara M; Sakata A; Miyashita T; Tamai I; Tsuji A
    J Pharm Sci; 1999 Dec; 88(12):1281-7. PubMed ID: 10585223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins.
    Uhr M; Holsboer F; Müller MB
    J Neuroendocrinol; 2002 Sep; 14(9):753-9. PubMed ID: 12213137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines.
    Ronaldson PT; Lee G; Dallas S; Bendayan R
    Pharm Res; 2004 May; 21(5):811-8. PubMed ID: 15180339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography.
    Hendrikse NH; Schinkel AH; de Vries EG; Fluks E; Van der Graaf WT; Willemsen AT; Vaalburg W; Franssen EJ
    Br J Pharmacol; 1998 Aug; 124(7):1413-8. PubMed ID: 9723952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
    Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
    Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
    Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
    J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pharmacologic and genetic knockout of P-glycoprotein on nelfinavir levels in the brain and other tissues in mice.
    Salama NN; Kelly EJ; Bui T; Ho RJ
    J Pharm Sci; 2005 Jun; 94(6):1216-25. PubMed ID: 15858856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of oral bioavailability and brain distribution of the Ind(8)-Val conjugate of indinavir in rodents.
    Pereira de Oliveira M; Olivier JC; Pariat C; Roche D; Greiner J; Vierling P; Couet W
    J Pharm Pharmacol; 2005 Apr; 57(4):453-8. PubMed ID: 15831205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.